CORE--CLINICAL
CORE--CLINICAL
批准号:
6453039
负责人:
MARK A JACOBSON
金额:
$13.19万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-05-10 至 2003-02-28
中文摘要
CFAR/CSG临床核心将提供一个多学科的机制
基础、临床和行为科学家之间的协作需要解决
创新的研究问题对更好地了解艾滋病毒很重要
艾滋病毒的发病机制或更好的诊断或治疗方法
疾病。具体地说,这一核心将促进
通过提供1)专家临床研究,进行基础和临床艾滋病毒研究
咨询,以帮助基础科学家开发出最
适当的协议设计,用于测试他们的特定假设,2)
有经验的临床研究人员招募受试者和
实现协议,从而为基础科学家提供开发
具体假设检验所需的最合适样本,3)
向基础科学家和临床研究人员提供行为专业知识
协助他们构思和实施研究方案和
解释发现,以及行为科学家有机会
临床中与行为研究问题相关的检验假设
人口。专家临床咨询服务包括
医学传染病/临床试验副教授
专家,研究药剂师/协调员,副教授
生物统计学,谁将担任行为研究的协调员
临床核心单位,每个单位都有8年或以上的学术经验,
加州大学旧金山分校与艾滋病毒相关的临床研究经验。核心董事和
研究协调员已经协调了动态的艾滋病毒临床研究
计划作为旧金山综合医院,整合到
拥有超过3,000名患者的门诊
在艾滋病毒疾病的不同阶段。核心主任、研究协调人
行为研究单位的科学家们已经合作进行了一项
测试特定假设的多学科研究的数量
从基础研究中涌现出来。全面的临床核心服务将提供
咨询研究人员以确定最佳研究设计,
书面研究方案和受试者知情同意的准备
表格,获得IRB批准;维护所需的IRBG
礼宾函件、招募受试者、取得和
向调查员提供所有特定于方案的样本
临床数据,超低温下标本的长期保存
标本库和行为评估。这些服务将
使不同的调查人员和多学科团队能够
研究人员,以有效地探索创新假设,范围
从HIV分子生物学的临床研究到行为学
妇女和少数民族治疗反应中的辅助因素研究。
英文摘要
The CFAR/CSG Clinical Core will provide a mechanism for multidisciplinary
collaboration among basic, clinical and behavioral scientistic to address
innovative research questions important to a better understanding of HIV
disease pathogenesis or better methods of diagnosis or treatment of HIV
disease. Specifically, this Core will facilitate translation between
basic and clinical HIV research by providing 1) expert clinical research
consultation to assist basic scientists in developing the most
appropriate protocol design for testing their specific hypotheses, 2)
experienced clinical research staff personnel to recruit subjects and
implement protocols thus providing basic scientists in developing the
most appropriate specimens needed for specific hypothesis testing, 3)
behavioral expertise to basic scientists and clinical researchers to
assist them in conceptualizing and implementing research protocols and
interpreting findings, and 4) behavioral scientists the opportunity to
test hypotheses relevant to behavioral research questions in clinical
populations. The expert clinical consultation service includes an
associate professor of medicine infectious diseases/clinical trials
specialist a research pharmacist/coordinator, an associate professor of
biostatistics, who will serve as coordinator of the Behavioral Research
Unit within in the Clinical Core, each with 8 or more years of academic,
HIV-related clinical research experience at UCSF. The Core Director and
Research Coordinator already coordinate a dynamic HIV clinical research
program as San Francisco General Hospital that is integrated into an
outpatient clinic with a patients base of greater than 3,000 individuals
at various stages of HIV disease. The Core Director, Study Coordinator
and scientists in the Behavioral Research Unit already collaborate on a
number of multidisciplinary studies to test specific hypotheses that
emerge from basic research. The full Clinical Core service will provide
consultation with the investigators to determine optimal study design,
preparation of a written study protocol and subjects informed consent
form, obtaining IRB approval and ;maintaining required IRBG
correspondence for the protocol, recruitment of subjects, obtaining and
providing investigator with all protocol-specific specimens are relevant
clinical data, long-term storage of specimens in an ultra-low temperature
specimen repository, and behavioral assessments. These services will
enable different investigators, and multidisciplinary teams of
investigators, to efficiently explore innovative hypotheses, ranging
from clinical studies of the molecular biology of HIV to behavioral
studies of cofactors in treatment response among women and minorities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV Epitope Specific T Cell Responses and Control of HIV Replication
-
批准号:7282098
-
项目类别:
-
资助金额:$23.09万
-
财政年份:2007
-
负责人:MARK A JACOBSON
-
依托单位:
Aberrant T Cell Function and Immunopathogenesis of CMV Immune Recovery Uveitis
-
批准号:7336264
-
项目类别:
-
资助金额:$23.11万
-
财政年份:2007
-
负责人:MARK A JACOBSON
-
依托单位:
HIV Epitope Specific T Cell Responses and Control of HIV Replication
-
批准号:7417845
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2007
-
负责人:MARK A JACOBSON
-
依托单位:
Aberrant T Cell Function and Immunopathogenesis of CMV Immune Recovery Uveitis
-
批准号:7489883
-
项目类别:
-
资助金额:$18.93万
-
财政年份:2007
-
负责人:MARK A JACOBSON
-
依托单位:
CMV Immune Response & Long-Term Outcome of CMV Retinitis
-
批准号:6745723
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2004
-
负责人:MARK A JACOBSON
-
依托单位:
CMV Immune Response & Long-Term Outcome of CMV Retinitis
-
批准号:6848025
-
项目类别:
-
资助金额:$25.92万
-
财政年份:2004
-
负责人:MARK A JACOBSON
-
依托单位:
THE ROLE OF PROTEIN LOOP FLEXIBILITY IN SUBSTRATE BINDING
-
批准号:7181783
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2004
-
负责人:MARK A JACOBSON
-
依托单位:
AACTG 5079: PHYSIOLOGIC TESTOSTERONE
-
批准号:7203030
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2004
-
负责人:MARK A JACOBSON
-
依托单位:
ADJUVANT RHIL-12 WITH A CYTOMEGALOVIRUS
-
批准号:7203039
-
项目类别:
-
资助金额:$30.09万
-
财政年份:2004
-
负责人:MARK A JACOBSON
-
依托单位:
AACTG 5079: Physiologic testosterone
-
批准号:7044942
-
项目类别:
-
资助金额:$0.57万
-
财政年份:2003
-
负责人:MARK A JACOBSON
-
依托单位:
A5159: HIV protease inhibitors and calcium channel blockers
-
批准号:7044955
-
项目类别:
-
资助金额:$0.57万
-
财政年份:2003
-
负责人:MARK A JACOBSON
-
依托单位:
ADJUVANT RHIL-12 WITH A CYTOMEGALOVIRUS
-
批准号:7044951
-
项目类别:
-
资助金额:$4.95万
-
财政年份:2003
-
负责人:MARK A JACOBSON
-
依托单位:
ACTG 5077: HAART/HIV compartments
-
批准号:7044920
-
项目类别:
-
资助金额:$0.98万
-
财政年份:2003
-
负责人:MARK A JACOBSON
-
依托单位:
AACTG A5082: Metformin/ Rosiglitazone
-
批准号:7044930
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2003
-
负责人:MARK A JACOBSON
-
依托单位:
Adjunct rhIL-12 enhance THI response to viral vaccine?
-
批准号:6467926
-
项目类别:
-
资助金额:$50.48万
-
财政年份:2002
-
负责人:MARK A JACOBSON
-
依托单位:
Adjunct rhIL-12 enhance THI response to viral vaccine?
-
批准号:6623575
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2002
-
负责人:MARK A JACOBSON
-
依托单位:
Adjunct rhIL-12 enhance THI response to viral vaccine?
-
批准号:6737543
-
项目类别:
-
资助金额:$10.37万
-
财政年份:2002
-
负责人:MARK A JACOBSON
-
依托单位:
CORE--CLINICAL
-
批准号:6507450
-
项目类别:
-
资助金额:$16.54万
-
财政年份:2001
-
负责人:MARK A JACOBSON
-
依托单位:
CORE--CLINICAL
-
批准号:6302657
-
项目类别:
-
资助金额:$34.93万
-
财政年份:2000
-
负责人:MARK A JACOBSON
-
依托单位:
CORE--ADVANCED TECHNOLOGY LABORATORIES
-
批准号:6099319
-
项目类别:
-
资助金额:$15.75万
-
财政年份:1999
-
负责人:MARK A JACOBSON
-
依托单位:
海外基金